Neuropsychopharmacology

mRNA and Protein Expression of Selective Alpha Subunits of G Proteins are Abnormal in Prefrontal Cortex of Suicide Victims
pp. 499-517(19)
Authors: Dwivedi Y.; Rizavi H.S.; Conley R.R.; Roberts R.C.; Tamminga C.A.; Pandey G.N.

Early Neonatal Experience of Long-Evans Rats Results in Long-lasting Changes in Reactivity to a Novel Environment and Morphine-induced Sensitization and Tolerance
pp. 518-533(16)
Authors: Kalinichev M.; Easterling K.W.; Holtzman S.G.

Nicotine Interactions with Haloperidol, Clozapine and Risperidone and Working Memory Function in Rats
pp. 534-541(8)
Authors: Addy N.; Levin E.D.

Ondansetron Given in the Acute Withdrawal from a Repeated Cocaine Sensitization Dosing Regimen Reverses the Expression of Sensitization and Inhibits Self-administration
pp. 542-553(12)
Authors: Davidson C.; Lee T.H.; Xiong Z.; Ellinwood E.H.

Role of Gi Proteins in the Antidepressant-like Effect of Amitriptyline and Clomipramine
pp. 554-564(11)
Authors: Galeotti N.; Bartolini A.; Ghelardini C.

Amphetamine Increases Phosphorylation of Extracellular Signal-regulated Kinase and Transcription Factors in the Rat Striatum via Group I Metabotropic Glutamate Receptors
pp. 565-575(11)
Authors: Choe E.S.; Chung K.T.; Mao L.; Wang J.Q.

Differential Effects of the 5-HT_2A Receptor Antagonist M100,907 and the 5-HT_2C Receptor Antagonist SB242,084 on Cocaine-induced Locomotor Activity, Cocaine Self-administration and Cocaine-induced Reinstatement of Responding
pp. 576-586(11)
Authors: Fletcher P.J.; Grottick A.J.; Higgins G.A.

Antidepressant-like Profile and Reduced Sensitivity to Rolipram in Mice Deficient in the PDE4D Phosphodiesterase Enzyme
pp. 587-595(9)
Authors: Zhang H.-T.; Huang Y.; Jin S.-L.C.; Frith S.A.; Suvarna N.; Conti M.; O'Donnell J.M.

A Pharmacokinetic and Pharmacodynamic Drug Interaction Study of Acamprosate and Naltrexone
pp. 596-606(11)
Authors: Mason B.J.; Goodman A.M.; Dixon R.M.; Hameed M.H.A.; Hulot T.; Wesnes K.; Hunter J.A.; Boyeson M.G.

opaminergic System Genes in ADHD - Toward a Biological Hypothesis
pp. 607-619(13)
Authors: Kirley A.; Hawi Z.; Daly G.; McCarron M.; Mullins C.; Millar N.; Waldman I.; Fitzgerald M.; Gill M.

Supraphysiological Doses of L-Thyroxine in the Maintenance Treatment of Prophylaxis-Resistant Affective Disorders
pp. 620-628(9)
Authors: Bauer M.; Berghofer A.; Bschor T.; Baumgartner A.; Kiesslinger U.; Hellweg R.; Adli M.; Baethge C.; Muller-Oerlinghausen B.

The Adenosine Antagonist Theophylline Impairs P50 Auditory Sensory Gating in Normal Subjects
pp. 629-637(9)
Authors: Ghisolfi E.S.; Prokopiuk A.S.; Becker J.; Ehlers J.A.; Belmonte-de-Abreu P.; Souza D.O.; Lara D.R.

Repetitive Transcranial Magnetic Stimulation (rTMS) in Major Depression - Relation between Efficacy and Stimulation Intensity
pp. 638-645(8)
Authors: Padberg F.; Zwanzger P.; Keck M.E.; Kathmann N.; Mikhaiel P.; Ella R.; Rupprecht P.; Thoma H.; Hampel H.; Toschi N.; Moller H.-J.

Central Serotonergic Activity is Related to the Aggressive Behaviors of Alzheimer's Disease
pp. 646-654(9)
Authors: Lanctot K.L.; Herrmann N.; Eryavec G.; van Reekum R.; Reed K.; Naranjo C.A.

A Quantitative Trait Locus Analysis of the Dopamine Transporter Gene in Adults with ADHD
pp. 655-662(8)
Authors: Muglia P.; Jain U.; Inkster B.; Kennedy J.L.

Aging and Panicogenic Response to Cholecystokinin Tetrapeptide - An Examination of the Cholecystokinin System
pp. 663-671(9)
Authors: Flint A.; Bradwejn J.; Vaccarino F.; Gutkowska J.; Palmour R.; Koszycki D.

Schizophrenia - Breakdown in the Well-regulated Lifelong Process of Brain Development and Maturation
pp. 672-683(12)
Author: Bartzokis G.

Nicotine Decreases Bradykinesia-rigidity in Haloperidol-treated Patients with Schizophrenia
pp. 684-686(3)
Authors: Yang Y.K.; Nelson L.; Kamaraju L.; Wilson W.; McEvoy J.P.